Copyright © 1999 by the European Society of Cardiology.
Letters to the Editor
Letters to the Editor
Harmostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, U.K
References
- Schirmer H, Lunde P, Rasmussen K. Prevalence of left ventricular hypertrophy in a general population: The Tromsø Study. Eur Heart J. 1999;20:429438
[Abstract/Free Full Text] - Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol. 1987;59:956960[CrossRef][ISI][Medline]
- Mayet J, Thom SAMcG. Left ventricular hypertrophy: a population perspective. Eur Heart J. 1999;20:400401[ISI][Medline]
- Gottdiener JS, Reda DJ, Materson BJ. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 1994;24:14921498[Abstract]
- Hinderliter AL, Light KC, Willis PW. Racial differences in left ventricular structure in healthy young adults. Am J Cardiol. 1992;69:11961199[CrossRef][ISI][Medline]
- Lip GYH, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol. 1997;80:15661571[CrossRef][ISI][Medline]
- Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circ. 1994;90:17861793
[Abstract/Free Full Text] - Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:15611566[Abstract]
- Stone MC, Thorpe JM. Plasma fibrinogena major coronary risk factor. J Roy Coll Gen Prac. 1985;35:565569
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||